Summary
The methods summarized in this chapter provide approaches for characterizing the specificity of a drug or hormone effect. This specificity provides evidence for a receptor-mediated response. Once a receptor is implicated in a response, a variety of analyses are available for estimating the equilibrium dissociation constants for agonists, partial agonists, antagonists and inverse agonists. It is clear that evaluation of receptor-mediated response provides a great deal of information, both qualitatively and quantitatively, regarding ligand-receptor interactions and subsequent receptor-activated responses. These approaches were developed when the biological preparation under study was intact tissue or native target cells. However, in current high throughput screening technologies where the read-out is a cell-based response, these strategies have comparable value in elucidating the mechanism and providing quantitative parameters to describe the properties of novel agents. In fact, the only receptor parameter that cannot be obtained from studies of dose-response relationships in intact cell or tissue preparations is receptor density. Radioligand binding methods for characterization of receptors yielding information concerning receptor specificity, affinity and density are discussed in chapter 3.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
General
Ahlquist, R.P. (1948) A study of the adrenotropic receptors. Am. J. Physiol. 155: 586–600.
Arunlakshana, O. and Schild, H.O. (1959) Some quantitative uses of drug antagonists. Brit. J. Pharm. 14:48–58.
Barlow, R., Scott, N.C. and Stephenson, R.P. (1967) Brit. J. Pharmacol. 31:188–196. Colquhoun, D. (1973) The relation between classical and cooperative models for drug action. In Drug Receptors, H.P. Rang (ed.), pp. 149–182. Baltimore: University Park Press.
Black, J.W., Gershkowitz, V.P., Leff, P. and Shankley, N.P. (1986) Analysis of competitive antagonism when this property occurs as part of a pharmacological resultant. Brit. J. Pharm. 89:547–555.
DeLean, A., Stadel, J.M. and Lefkowitz, R.J. (1980) A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor. J. Biol. Chem. 255:7108–7117.
Furchgott, R.F. (1972) The classification of adrenoceptors (adrenergic receptors): An evaluation from the standpoint of receptor theory. In Handbuch der Experimentellen Pharmakologie, vol. 33, Catecholamines, H. Blashko and E. Muscholl (eds.), pp. 283–335. Berlin: Springer-Verlag.
Furchgott, R.F. (1978) Pharmacological characterization of receptors: Its relation to radioligand-binding studies. Fed. Proc. 37: 115–120.
Gaddum, J.H. (1937) The quantitative effects of antagonist drugs. J. Physiol. (London) 89:79–9P.
Gaddum, J.H. (1943) Biological aspects: The antagonism of drugs. Trans. Faraday Soc. 39:323–333.
Gaddum, J.H. (1957) Theories of drug antagonism. Pharm. Rev. 9:211–217.
Kenakin, T.P. (1984a) The classification of drugs and drug receptors in isolated tissues. Pharmacol. Rev. 36: 165–222.
Kenakin, T.P. (1987a) The Pharmacological Analysis of Drug Receptor Interaction. NY: Raven Press.
Kenakin, T.P. (1987b) What can we learn from models of complex drug antagonism in classifying hormone receptors? In Perspectives on Receptor Classification, Receptor Biochemistry and Methodology, vol. 6, pp. 167–185. Black, J.W., Jenkinson, D.H. and Gershkowitz, V.P. (eds.). NY: Alan R. Liss.
Kenakin, T.P. (2001) Quantitation in Receptor Pharmacology. Rec. & Chan. 7:371–385.
Kenakin, T.P. (2004) A Pharmacology Primer: Theory, Methods, and Application. San Diego: Elsevier Press, Inc.
MacKay, D. (1966) A general analysis of the receptor-drug interaction. Brit. J. Pharmacol. 26:9–16.
MacKay, D. (1978) How should values of pA2 and affinity constants for pharmacological competitive antagonists be evaluated? J. Pharm. Pharmac. 30:312–313.
MacKay, D. (1982) Dose-response curves and mechanisms of drug action. Trends in Pharm. Sci. 2:496–499.
Parker, R.B. and Waud, D.R. (1971) Pharmacological estimation of drug-receptor dissociation constants: Statistical evaluation. I. Agonists. J. Pharm. Exp. Ther. 177:1–12.
Schild, H.O. (1947) pA, a new scale for the measurement of drug antagonism. Brit. J. Pharm. 2: 189–206.
Schild, H.O. (1957) Drug antagonism and pAx. Pharm. Rev. 9:242–245.
Schild, H.O. (1973) Receptor classification with special reference to β-adrenergic receptors. In Drug Receptors, pp. 29–36, H.P. Rang (ed.). Baltimore: University Park Press.
Stephenson, R.P. (1956) A modification of receptor theory. Brit. J. Pharm. 11: 379–393.
Thron, C.D. (1973) On the analysis of pharmacological experiments in terms of an allosteric receptor model. Mol. Pharmacol 9:1–9.
Van Rossum, J.M. (1963) Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch. Int. Pharmacodyn. Ther. 143:299–330.
Waud, D.R. (1969) On the measurement of the affinity of partial agonists for receptors. J. Pharm. Exp. Ther. 170: 117–122.
Specific
Berg K.A., Maayani, S., Goldfarb, J., Scaramellini, C., Leff, P. and Clarke, W.P. (1998) Effector Pathway-Dependent Relative Efficacy at Serotonin Type 2A and 2C Receptors: Evidence for Agonist-Directed Trafficking of Receptor Stimulus. Mol. Pharm. 54:94–104.
Berthelson, S. and Pettinger, W.A. (1977) A functional basis for classification of α-adrenergic receptors. Life Sci. 21:595–606.
del Castillo, J. and Katz, B. (1957) Interaction at endplate receptors between different choline derivatives. Proc. Royal Soc. Lond., Series B, 146:369–381.
Furchgott, R.F. (1954) Dibenamine blockade in strips of rabbit aorta and its use in differentiating receptors. J. Pharm. Exp. Ther. 111:265–284.
Furchgott, R.F. (1966) The use of (β-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes. In Advances in Drug Research, vol. 3, pp. 21–55. Harper, N.J. and Simmonds, A.B. (eds.). New York: Academic Press.
Furchgott, R.F. and Bursztyn, P. (1967) Comparison of dissociation constants and relative efficacies of selective agonists acting on parasympathetic receptors. Ann. NY Acad. Sci. 139:882–889.
Kaumann, A.J. and Marano, M. (1982) On equilibrium dissociation constants for complexes of drug receptor subtypes: selective and nonselective interactions of partial agonists with two (β-adrenoceptor subtypes mediating positive chronotropic effects of (-) isoprenaline in kitten atria. Naunyn Schmiedebergs Arch. Pharmacol. 219:216–221.
Kenakin, T.P. (1984b) The relative contribution of affinity and efficacy to agonist activity: organ selectivity of noradrenaline and oxymetazoline with reference to the classification of drug receptors. Br. J. Pharmacol. 81(1): 131–141.
Kenakin, T.P. and Boselli, C. (1989) Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea. J. Pharmacol. Exp. Ther. 250(3):944–952.
Kono, T. and Barham, F.W. (1971) The relationship between the insulin-binding capacity of fat cells and the cellular response to insulin. J. Biol. Chem. 246: 6210–6216.
Kuwasako, K., Cao Y-N., Nagoshi, Y., Tsuruda, T., Kitamura, K. and Eto, T. (2004) Characterization of the Human Calcitonin Gene-Related Peptide Receptor Subtypes Associated with Receptor Activity-Modifying Proteins. Mol. Pharm. 65:207–213.
Langer, S.Z. and Trendelenberg, U. (1960) The effect of a saturable uptake mechanism on the slope of dose-response curves for sympathomimetic amines and on the shifts of dose-response curves produced by a competitive antagonist. J. Pharm. Exp. Ther. 167:117–142.
Leff, P., Dougall, I.G., Harper, D.H. and Dainty, I.A. (1990) Errors in agonist affinity estimation: Do they and should they occur in isolated tissue experiments? Trends in Pharm. Sci. 11:64–67.
Lefkowitz, R.J., Cotecchia, S., Samama, P. and Costa, T. (1993) Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends in Pharm. Sci. 14:303–307.
Lin, C.W. and Musacchio, J.M. (1983) The determination of dissociation constants for substance P and substance P analogues in the guinea pig ileum by pharmacological procedures. Mol. Pharmacol. 23:558–562.
Paton, W.D.M. and Rang, H.P (1965) The uptake of atropine and related drugs by intestinal smooth muscle of the guinea pig in relation to acetylcholine receptors. Proc. R. Soc. Lond. B. 163:1–44.
Schultz, R., Wuster, M., Krenss, H. and Hers, A. (1980) Lack of cross-tolerance on multiple opiate receptors in the vas deferens. Mol. Pharmacol. 18:395–401.
Schütz, W. and Freissmuth, W.B. (1992) Reverse intrinsic activity of antagonists on G protein-coupled receptors. Trends in Pharm. Sci. 13:376–380.
Sine, S.M. and Taylor, P. (1981) Relationship between reversible antagonist occupancy and the functional capacity of the acetylcholine receptor. J. Biol. Chem. 256:6692–6699.
Tallarida, R.J., Cowan, A. and Adler, M.W. (1979) pA2 and receptor differentiation: A statistical analysis of competitive antagonism (minireview). Life Sci. 25:637–654.
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
(2005). Characterization of Receptors Based on Receptor-Mediated Responses. In: Cell Surface Receptors. Springer, Boston, MA. https://doi.org/10.1007/0-387-23080-7_2
Download citation
DOI: https://doi.org/10.1007/0-387-23080-7_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-23069-6
Online ISBN: 978-0-387-23080-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)